Indian Journal of Clinical and Experimental Ophthalmology
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Original Article
Author Details :
Volume : 8, Issue : 1, Year : 2022
Article Page : 13-19
https://doi.org/10.18231/j.ijceo.2022.004
Abstract
Aim: To study the response to the injection of intra-vitreal triamcinolone acetate (IVTA) in various indications and to identify the IOP rise between various groups.
Materials and Methods: An interventional, prospective study was conducted on 50 patients at vitreo-retinal department at tertiary eye hospital in Bangalore in the period of November 2015 to May 2017. Each patient was subjected to a detailed assessment which included patient’s demographic data & detailed history. Best corrected visual-acuity (BCVA), Intra ocular pressure(IOP) was recorded. Macular oedema is confirmed by optical coherence tomography and fluorescein angiography. Patients that received injection IVTA were followed up for 6 months.
Results: The mean age of subjects was 56.78±10.76 years, 54% were males and 46% were females. In the study, 46% of eyes were diagnosed at CSME, 38% as BRVO, 8% as pseudophakic CME, 6% as CRVO and 2% as Uveitis. The mean BCVA LogMAR at baseline was 0.87±0.43 and at 6 months follow up mean BCVA LogMAR was 0.59 ± 0.42. In the study mean IOP at baseline was 14.24±3.01 and at 6 months follow up mean IOP was 15.12 ± 3.60. There was significant increase in IOP at 1 month follow up. The mean central macular thickness (CMT) at baseline was 469.4±138.4 and at 6 months follow up mean CMT was 290.9 ± 140.7.
Conclusion: Although there is a risk of raised IOP, IVTA can be preferred as a modality of treating macular edema as it has good results and is very economical and affordable.
Keywords: IVTA, IOP, Macular oedema.
How to cite : Kalpana S, Prabhakar S P, Fauzia A, Outcome of intravitreal triamcinolone (IVTA) acetonide in various posterior segment disorder. Indian J Clin Exp Ophthalmol 2022;8(1):13-19
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
